BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis (MS), has today announced that leading NonTuberculous Mycobacterium (NTM) research scientist, Dr. Rahul Narang, will be showcasing the Designer Diagnostics test kit technology in an upcoming presentation at the 38th Union World Conference on Lung Health in South Africa. Designer Diagnostics is a wholly-owned subsidiary of Nutra Pharma Corp.
